Home  >  Products  >  TFPI (tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) ) Blocking Peptide (the C terminal of TFPI)(100ug)
TFPI (tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) ) Blocking Peptide (the C terminal of TFPI)(100ug)

TFPI (tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) ) Blocking Peptide (the C terminal of TFPI)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-TFPI Antibody (ARP63091_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63091
Size: 100ug
Weight: 33kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This gene encodes a protease inhibitor that regulates the tissue factor (TF)-dependent pathway of blood coagulation. The coagulation process initiates with the formation of a factor VIIa-TF complex, which proteolytically activates additional proteases (factors IX and X) and ultimately leads to the formation of a fibrin clot. The product of this gene inhibits the activated factor X and VIIa-TF proteases in an autoregulatory loop. The encoded protein is glycosylated and predominantly found in the vascular endothelium and plasma in both free forms and complexed with plasma lipoproteins. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been confirmed.
Alternative names: EPI; LACI; TFI; TFPI1
See Full Product Listings >